As RHOA mutations are highly prevalent in AITL and have been found to cause activation of the MAPK/PI3K/AKT pathway and T cell receptor signaling, the hotspot mutation G17V was also screened [23,24]. The gene discussed is AKT1; the disease is angioimmunoblastic T-cell lymphoma.